Featured Clinical Leader Editorial
-
FDA Draft Guidance On “Rare Diseases: Considerations For The Development Of Drugs And Biological Products”
1/26/2024
Accenture Applied Life Science Solutions' Raj Bandaru, Ph.D. breaks down, summarizes, and shares detailed insight on the recent FDA Draft Guidance that addresses “Rare Diseases: Considerations for the Development of Drugs and Biological Products.”
-
3 Ways Biotechs Can Lower The Cost Of Clinical Trials
1/23/2024
LongeVC has identified three innovative models to help biotechs lower the cost of their clinical trials.
-
Understanding Precision Neuroscience As Treatment For Rare Autoantibody Disease
1/19/2024
J&J Innovative Medicine develops precision therapeutics in neuroscience, reducing the trial participation and treatment burdens on people living with generalized myasthenia gravis.
-
A Closer Look At Precision Medicine Clinical Trials
1/9/2024
As Sumitomo Pharma America (SMPA) starts to focus more on precision medicine, the sponsor is encountering a new set of challenges when it comes to running clinical trials.
-
Which Therapeutic Areas Experts Think Will Gain Traction In 2024
1/2/2024
In part four, experts discuss several therapeutic areas and their advancements they believe deserve and will garner interest in 2024.
-
The Current State Of Sustainability In Clinical Trials
12/19/2023
From exploring decentralized trial elements to making operations carbon-negative, the clinical research industry is aligning its goals with broader global sustainability initiatives.
-
How Re-educating PIs Can Improve Clinical Trial Diversity
12/14/2023
Usually, discussions around ways to improve diversity in clinical trials focus on changing traditional protocol-design processes, finding and tapping into larger pools of diverse patients, educating patients on the value of clinical trials — that type of stuff. You don't normally hear people talking about re-educating physicians as a solution.
-
New Calculator Could Help Trial Participants And Sponsors Determine Costs And Fair Compensation
12/14/2023
Try the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face.
-
Trip Or No Trip: Pharmas Are Taking Psychedelic Trials To Australia
12/13/2023
Enveric Biosciences CEO Joseph Tucker, Ph.D., chronicles the company's quest for regulatory approval in Australia, as well as navigates the unknowns of developing psychedelics for therapeutic use.
-
Who Are Your TMF Customers? The Key To Greater Trial Efficiency & Quality
12/12/2023
Could your director of clinical operations or TMF manager identify all customers of the TMF? Perhaps not. Learn why knowing all customers is so important to efficient, high-quality trials.